← Back to guidelines
Cardiology10 papers

Perivascular epithelioid cell tumor

Last edited: 4/23/2026

Overview

Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal neoplasm characterized by cells with clear or granular cytoplasm, positive for melanocytic and smooth muscle markers. 1

Diagnosis

  • Imaging (CT, MRI) often reveals a mass with nonspecific characteristics.
  • Definitive diagnosis requires histopathological examination showing perivascular arrangement and immunohistochemical positivity for markers like HMB45, Melan-A, and smooth muscle actin.
  • No specific grading system universally accepted; morphology and mitotic activity may guide assessment. 1
  • Management

  • Surgical excision is the primary treatment modality for localized PEComas.
  • Adjuvant therapy (chemotherapy, radiation) is considered for high-risk features or metastatic disease, though specific regimens are not detailed in current abstracts.
  • Follow-up imaging and clinical monitoring essential due to potential for recurrence or metastasis. 1
  • Special Populations

  • No specific data provided regarding PEComa in pregnancy, pediatrics, elderly, or patients with comorbidities in the given abstracts. 1
  • Key Recommendations

  • Definitive diagnosis of PEComa requires histopathological confirmation with characteristic immunohistochemical markers. (Evidence: Weak) 1
  • Surgical resection should be considered the first-line treatment for localized PEComa. (Evidence: Expert opinion) 1
  • Post-surgical surveillance is crucial due to the risk of recurrence or metastasis. (Evidence: Expert opinion) 1
  • References

    1 Geramizadeh B, Salehzadeh A, Ghazinoor M, Moaref A, Mollazadeh R. Perivascular epithelioid cell tumor of the pericardium: a case report. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2008. link

    Original source

    1. [1]
      Perivascular epithelioid cell tumor of the pericardium: a case report.Geramizadeh B, Salehzadeh A, Ghazinoor M, Moaref A, Mollazadeh R Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (2008)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG